Products
16709 Results
Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Newmont Constant Leverage with ISIN code: CH1210506338 | Newmont | Constant Leverage | Short | ― | 43.35 | 0.76 | 0.030 | 0.79 | 1 | -2.56 % | -17.39 % | -30.28 % | 15 Sep. 2022 | |
Nike Constant Leverage with ISIN code: CH1345999515 | Nike | Constant Leverage | Long | ― | 75.514 | 0.04 | 0.003 | 0.043 | 1 | -4.76 % | -99.46 % | -99.51 % | 18 Apr. 2024 | |
Nike Constant Leverage with ISIN code: CH1345999523 | Nike | Constant Leverage | Long | ― | 75.514 | 0.035 | 0.003 | 0.038 | 1 | -5.41 % | -99.46 % | -99.54 % | 18 Apr. 2024 | |
Nike Constant Leverage with ISIN code: CH1119067986 | Nike | Constant Leverage | Long | ― | 75.514 | 0.15 | 0.030 | 0.18 | 1 | -6.25 % | -80.52 % | -81.25 % | 12 May. 2022 | |
Nike Constant Leverage with ISIN code: CH1119067994 | Nike | Constant Leverage | Short | ― | 75.514 | 2.94 | 0.040 | 2.98 | 1 | -2.33 % | 76.05 % | 79.27 % | 12 May. 2022 | |
Nike Constant Leverage with ISIN code: CH1345999507 | Nike | Constant Leverage | Short | ― | 75.514 | 18.11 | 0.340 | 18.45 | 1 | -3.31 % | 114.32 % | 114.83 % | 18 Apr. 2024 | |
Nokia Constant Leverage with ISIN code: CH1235293177 | Nokia | Constant Leverage | Long | ― | 3.623 | 0.24 | 0.010 | 0.25 | 1 | 0.00 % | 33.33 % | -11.11 % | 30 Nov. 2022 | |
Nokia Constant Leverage with ISIN code: CH1119067226 | Nokia | Constant Leverage | Long | ― | 3.623 | 0.83 | 0.010 | 0.84 | 1 | 1.22 % | 18.57 % | -5.68 % | 6 May. 2022 | |
Nokia Constant Leverage with ISIN code: CH1235293169 | Nokia | Constant Leverage | Short | ― | 3.623 | 6.52 | 0.030 | 6.55 | 1 | -3.55 % | -13.30 % | -3.98 % | 30 Nov. 2022 | |
Nokia Constant Leverage with ISIN code: CH1345998707 | Nokia | Constant Leverage | Short | ― | 3.623 | 2.83 | 0.020 | 2.85 | 1 | -5.03 % | -20.06 % | -8.41 % | 18 Apr. 2024 | |
Novartis Constant Leverage with ISIN code: CH1346746238 | Novartis | Constant Leverage | Long | ― | 97.1 | 13.45 | 0.050 | 13.5 | 1 | 3.46 % | 5.91 % | 17.47 % | 24 Apr. 2024 | |
Novartis Constant Leverage with ISIN code: CH1346746246 | Novartis | Constant Leverage | Long | ― | 97.1 | 15.25 | 0.100 | 15.35 | 1 | 5.17 % | 8.93 % | 26.03 % | 24 Apr. 2024 | |
Novartis Constant Leverage with ISIN code: CH1346746253 | Novartis | Constant Leverage | Long | ― | 97.1 | 17 | 0.150 | 17.15 | 1 | 6.92 % | 11.48 % | 33.86 % | 24 Apr. 2024 | |
Novartis Constant Leverage with ISIN code: CH1276587271 | Novartis | Constant Leverage | Long | ― | 97.1 | 12.34 | 0.050 | 12.39 | 1 | 4.22 % | 6.29 % | 17.64 % | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1276587305 | Novartis | Constant Leverage | Long | ― | 97.1 | 9.45 | 0.090 | 9.54 | 1 | 10.66 % | 15.81 % | 43.18 % | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1276587289 | Novartis | Constant Leverage | Long | ― | 97.1 | 12.19 | 0.070 | 12.26 | 1 | 6.37 % | 9.43 % | 26.19 % | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1276587297 | Novartis | Constant Leverage | Long | ― | 97.1 | 11.17 | 0.080 | 11.25 | 1 | 8.55 % | 12.60 % | 34.90 % | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1276587255 | Novartis | Constant Leverage | Short | ― | 97.1 | 3.05 | 0.020 | 3.07 | 1 | -4.98 % | -8.68 % | -26.33 % | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1276587263 | Novartis | Constant Leverage | Short | ― | 97.1 | 4.91 | 0.020 | 4.93 | 1 | -3.54 % | -5.76 % | -18.03 % | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1346746220 | Novartis | Constant Leverage | Short | ― | 97.1 | 6.67 | 0.030 | 6.7 | 1 | -4.58 % | -7.10 % | -19.15 % | 24 Apr. 2024 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.